LINC00261: A Protein Involved in Intracellular Signaling and Disease

Target Name: LINC00261

NCBI ID: G140828

LINC00261

LINC00261: A Protein Involved in Intracellular Signaling and Disease

LINC00261 (TCONS-00027846) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the TCON family of proteins, which are known for their role in intracellular signaling.

One of the functions of LINC00261 is to regulate the activity of the protein TrkB, which is involved in the intracellular signaling pathway known as the T-cell signaling pathway. This pathway is important for the development and maintenance of T-cells, which play a key role in immune responses.

In addition to its role in T-cell signaling, LINC00261 is also involved in the regulation of inflammation and cellular stress. It has been shown to play a role in the regulation of inflammation in response to infection or injury, as well as in the regulation of cellular stress caused by various environmental factors.

Furthermore, LINC00261 is also involved in the regulation of cell survival and metabolism. It has been shown to play a role in the regulation of cell proliferation, cell survival, and cellular metabolism.

In conclusion, LINC00261 is a protein that is involved in a variety of cellular processes in the body. Its function as a drug target or biomarker makes it an attractive target for research into various diseases, including cancer, autoimmune diseases, and metabolic disorders. Further research is needed to fully understand the role of LINC00261 in these processes and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 261

The "LINC00261 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00261 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets